REGULATED PRESS RELEASE published on 10/23/2023 at 15:18, 2 years 10 months ago Statement of transactions in own shares from October 16, 2023 to October 20, 2023
REGULATED PRESS RELEASE published on 10/16/2023 at 11:41, 2 years 11 months ago Statement of transactions in own shares from October 9, 2023 to October 13, 2023
REGULATED PRESS RELEASE published on 10/11/2023 at 20:35, 2 years 11 months ago Statement about the number of shares composing the share capital and the number of voting rights as at September 30, 2023
REGULATED PRESS RELEASE published on 10/09/2023 at 12:07, 2 years 11 months ago Statement of transactions in own shares from October 2, 2023 to October 6, 2023
REGULATED PRESS RELEASE published on 10/02/2023 at 15:28, 2 years 11 months ago Statement of transactions in own shares from September 25, 2023 to September 29, 2023
Published on 09/18/2026 at 06:30, 1 hour 48 minutes ago GREE Chairperson Dong Mingzhu Honored by UNEP Cool Coalition for Leadership in Sustainable Cooling
Published on 09/18/2026 at 00:55, 7 hours 23 minutes ago Tectonic Metals Announces Results of the 2026 Annual General Meeting
Published on 09/18/2026 at 00:25, 7 hours 53 minutes ago CoTec Holdings Corp. Announces Initial Closing of Private Placement of Unsecured Convertible Debentures
Published on 09/17/2026 at 22:15, 10 hours 3 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/18/2026 at 08:05, 12 minutes ago THE TOKYO PASS Renews Official Website, Redefining Wellness Tourism in Tokyo with "Museum Bathing (R)"
Published on 09/18/2026 at 08:00, 17 minutes ago Gledhow Investments plc: Appointment of Aquis Corporate Adviser
Published on 09/17/2026 at 17:40, 14 hours 38 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 14 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 2 days 1 hour ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification